Orchestra BioMed Holdings, Inc. Capital Expenditures
Orchestra BioMed Holdings, Inc. (OBIO) reported Capital Expenditures of $438.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $254.00K, a 647.06% increase year-over-year.
- Orchestra BioMed Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $184.00K, a 64.29% increase year-over-year.
- Orchestra BioMed Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $33.00K, a 68.87% decline year-over-year.
- Orchestra BioMed Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $310.00K, a 355.88% increase year-over-year.
- Orchestra BioMed Holdings, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $489.00K, a 69.20% increase from fiscal 2024.
- Orchestra BioMed Holdings, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $289.00K, a 270.51% increase from fiscal 2023.
- Orchestra BioMed Holdings, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $78.00K, a 86.80% decline from fiscal 2022.
- Orchestra BioMed Holdings, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $591.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $254.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $438.00K 10-Q · filed 2026-08-10 | $471.00K derived: sum of 3 quarters · filed 2026-08-10 | $781.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $184.00K 10-Q · filed 2026-05-12 | $217.00K derived: sum of 2 quarters · filed 2026-05-12 | $527.00K derived: sum of 3 quarters · filed 2026-05-12 | $561.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $343.00K derived: sum of 2 quarters · filed 2026-03-12 | $377.00K derived: sum of 3 quarters · filed 2026-08-10 | $489.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $310.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $344.00K derived: sum of 2 quarters · filed 2026-08-10 | $456.00K 10-Q · filed 2025-11-10 | $562.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $146.00K 10-Q · filed 2026-08-10 | $252.00K derived: sum of 3 quarters · filed 2026-08-10 | $320.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $112.00K 10-Q · filed 2026-05-12 | $218.00K derived: sum of 2 quarters · filed 2026-05-12 | $286.00K derived: sum of 3 quarters · filed 2026-05-12 | $393.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $174.00K derived: sum of 2 quarters · filed 2026-03-12 | $281.00K derived: sum of 3 quarters · filed 2026-03-12 | $289.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $175.00K derived: sum of 2 quarters · filed 2025-11-10 | $183.00K 10-Q · filed 2025-11-10 | $180.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $115.00K 10-Q · filed 2025-08-12 | $112.00K derived: sum of 3 quarters · filed 2025-08-12 | $131.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $8.00K 10-Q · filed 2025-05-12 | $5.00K derived: sum of 2 quarters · filed 2025-05-12 | $24.00K derived: sum of 3 quarters · filed 2025-05-12 | $51.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $16.00K derived: sum of 2 quarters · filed 2025-03-31 | $43.00K derived: sum of 3 quarters · filed 2025-03-31 | $78.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $46.00K derived: sum of 2 quarters · filed 2024-11-12 | $81.00K 10-Q · filed 2024-11-12 | $135.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $62.00K 10-Q · filed 2024-08-12 | $116.00K derived: sum of 3 quarters · filed 2024-08-12 | $340.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $35.00K 10-Q · filed 2024-05-13 | $89.00K derived: sum of 2 quarters · filed 2024-05-13 | $313.00K derived: sum of 3 quarters · filed 2024-05-13 | $579.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $278.00K derived: sum of 2 quarters · filed 2024-03-27 | $544.00K derived: sum of 3 quarters · filed 2024-03-27 | $591.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $224.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $490.00K derived: sum of 2 quarters · filed 2023-11-13 | $537.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $266.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $313.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $47.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |